Abstract
Mature cystic teratomas are the most common type of ovarian germ cell tumors. In about 1% of cases, usually among postmenopausal women, a mature cystic teratoma can undergo malignant transformation. Among malignant transformations, squamous cell carcinoma is the most common histology, comprising approximately 80% of cases. In this report, we present the unique case of a 55-yr-old woman with a pelvic mass found to be a mature cystic teratoma with malignant transformation to adenocarcinoma with breast/adnexal, upper gastrointestinal, and neuroendocrine differentiation. The predominant malignant component was the adenocarcinoma exhibiting breast/skin adnexal differentiation, which was found to involve the omentum and a right para-aortic node. We provide an in-depth review of the pathologic findings, as well as a review of the current literature on malignant transformation to adenocarcinoma. This report aims to open a conversation regarding the management of these patients, with a specific focus on the role of molecular analysis and targeted therapies.
MeSH terms
-
Adenocarcinoma / drug therapy
-
Adenocarcinoma / pathology*
-
Adenocarcinoma / surgery
-
Antineoplastic Agents / therapeutic use
-
Breast Neoplasms / drug therapy
-
Breast Neoplasms / pathology
-
Breast Neoplasms / surgery
-
Carcinoma, Squamous Cell / drug therapy
-
Carcinoma, Squamous Cell / pathology*
-
Carcinoma, Squamous Cell / surgery
-
Cell Transformation, Neoplastic
-
Cisplatin / therapeutic use
-
Female
-
Gastrointestinal Neoplasms / drug therapy
-
Gastrointestinal Neoplasms / pathology
-
Gastrointestinal Neoplasms / surgery
-
Humans
-
Middle Aged
-
Neoplasms, Germ Cell and Embryonal / drug therapy
-
Neoplasms, Germ Cell and Embryonal / pathology*
-
Neoplasms, Germ Cell and Embryonal / surgery
-
Ovarian Neoplasms / drug therapy
-
Ovarian Neoplasms / pathology*
-
Ovarian Neoplasms / surgery
-
Paclitaxel / therapeutic use
-
Skin Neoplasms / drug therapy
-
Skin Neoplasms / pathology
-
Skin Neoplasms / surgery
-
Teratoma / drug therapy
-
Teratoma / pathology*
-
Teratoma / surgery
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Paclitaxel
-
Cisplatin
Supplementary concepts
-
Ovarian Germ Cell Cancer
-
Teratoma, Ovarian